Ignite Creation Date:
2025-12-24 @ 2:03 PM
Ignite Modification Date:
2026-02-26 @ 8:11 PM
Study NCT ID:
NCT00169195
Status:
COMPLETED
Last Update Posted:
2015-09-02
First Post:
2005-09-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rituximab, Gemcitabine and Oxaliplatin (R-GEMOX) for Refractory/Relapsed B-cell Lymphoma
Sponsor:
Lymphoma Study Association
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-04
Start Date Type:
None
Primary Completion Date:
2012-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-11
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-12
First Submit QC Date:
None
Study First Post Date:
2005-09-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-09-01
Last Update Post Date:
2015-09-02
Last Update Post Date Type:
ESTIMATED